Yan Wang

Yan Wang, M.D., Ph.D. currently serves as the VP, Head of Business Development, Alliance Management, and Corporate Strategy at JW Therapeutics, a biotechnology company specializing in cell immunotherapy products. Prior to this role, Yan worked in various business development positions at IASO BioTherapeutics, IASO BIO USA, Simcere Pharmaceutical Group, and Adaptimmune. With a background in immunology and pharmacology, Yan has contributed significantly to the development and commercialization of innovative therapies for oncology.